AtaiBeckley (ATAI) FCF Margin (2021 - 2026)

AtaiBeckley (ATAI) recorded quarterly FCF Margin of 2210.69% in Q1 2026, down 89.83% quarter-over-quarter from 1164.57% in Q1 2025, and down 104613.0% on a YoY basis from N/an in Q1 2025.

AtaiBeckley (ATAI) FCF Margin (2021 - 2026) Analysis & Trends

AtaiBeckley has disclosed FCF Margin across 5 years of filings, most recently posting 3052.87% for Q3 2025.

  • FCF Margin for Q3 2025 came in at 3052.87%, up 4529963.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 2619.34% (up 2160543.0% YoY), and the FY2024 annual result was 26767.21%, up 12738.0% from the prior year.
  • FCF Margin was 2210.69% for Q1 2026 at AtaiBeckley, down from 1164.57% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1164.57% in Q1 2025 to a low of 2210.69% in Q1 2026.
  • The 5-year median for FCF Margin is 13065.17% (2022), against an average of 44334.26%.
  • Across the five-year window, FCF Margin plunged 10644583 bps in 2022 and soared 9604009 bps in 2023, its largest moves.
  • AtaiBeckley's FCF Margin stood at 9049.57% in 2021, then plunged by 805 bps to 81863.16% in 2022, then tumbled by 50 bps to 122455.56% in 2023, then sank by 65 bps to 202508.33% in 2024, then surged by 98 bps to 3052.87% in 2025.
  • The last three FCF Margin figures came in at 3052.87% (Q3 2025), 1977.89% (Q2 2025), and 1164.57% (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 AtaiBeckley 1.45 Bn 1.45 Bn - -2,210.69%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,210.69%
Sep 30, 2025 -3,052.87%
Jun 30, 2025 -1,977.89%
Mar 31, 2025 -1,164.57%
Mar 31, 2025 -1,164.57%
Dec 31, 2024 -202,508.33%
Sep 30, 2024 -48,352.50%
Jun 30, 2024 -5,944.32%
Dec 31, 2023 -122,455.56%
Sep 30, 2023 -21,105.75%
Jun 30, 2023 -13,170.93%
Mar 31, 2023 -57,813.51%
Dec 31, 2022 -81,863.16%
Sep 30, 2022 -117,145.83%
Jun 30, 2022 -12,959.41%
Dec 31, 2021 -9,049.57%
Sep 30, 2021 -10,700.00%
Mar 31, 2021 -84.00%